Coding Ahead
CasePilot
Medical Coding Assistant
Case2Code
Search and Code Lookup Tool
CareerCenter
Medical Coding Job Board
Log in Register free account

Need help choosing the right code?

Ask CasePilot about procedures, modifiers, bundling, and coding guidance.

Try CasePilot

Official Description

Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitative

© Copyright 2026 American Medical Association. All rights reserved.

Common Language Description

The CPT® Code 82010 refers to a quantitative test for ketone bodies in the blood, specifically measuring substances such as acetone, acetoacetic acid, and beta-hydroxybutyrate. This test is crucial for assessing the levels of ketone bodies, which are produced when the body breaks down fat for energy instead of carbohydrates. The presence of these ketone bodies can indicate various metabolic states, particularly in conditions where carbohydrate utilization is impaired. For instance, elevated levels of ketone bodies are commonly associated with diabetes mellitus, where the body cannot effectively use glucose due to insulin deficiency or resistance. Additionally, this test can be relevant in cases of malnutrition, anorexia, inadequate calorie intake, vomiting, and glycogen storage diseases. The quantitative aspect of this test distinguishes it from the qualitative test (CPT® Code 82009), which only determines the presence or absence of ketone bodies through a visual assessment. The qualitative test is often described as semi-quantitative due to its reliance on color changes to indicate low to high levels of ketones. In contrast, the quantitative test provides a precise measurement of ketone levels in the blood serum, which is essential for the evaluation and management of conditions such as diabetic and alcoholic ketoacidosis. This test is typically performed on a blood sample obtained through venipuncture, and the analysis is conducted using gas chromatography, a method that allows for accurate quantification of the ketone bodies present in the serum.

© Copyright 2026 Coding Ahead. All rights reserved.

1. Indications

The quantitative test for ketone bodies (CPT® Code 82010) is indicated for the following conditions:

  • Diabetes Mellitus - This test is essential for monitoring patients with diabetes, particularly those at risk for ketoacidosis, a serious complication that can arise when insulin levels are insufficient.
  • Malnutrition - In cases where patients are not receiving adequate nutrition, the body may resort to fat metabolism, leading to increased ketone production.
  • Anorexia - Similar to malnutrition, anorexia can result in insufficient caloric intake, prompting the body to produce ketones as an alternative energy source.
  • Inadequate Calorie Intake - Any condition that leads to reduced caloric consumption can trigger ketone body formation, making this test relevant for assessment.
  • Vomiting - Persistent vomiting can lead to dehydration and metabolic changes, including increased ketone levels.
  • Glycogen Storage Disease - This group of inherited disorders affects the body's ability to store and utilize glycogen, potentially leading to elevated ketone levels.

2. Procedure

The procedure for conducting the quantitative test for ketone bodies involves several key steps:

  • Step 1: Patient Preparation - Prior to the test, the patient may be instructed to fast or avoid certain foods that could affect ketone levels. It is essential to ensure that the patient understands the importance of following these guidelines for accurate results.
  • Step 2: Blood Sample Collection - A blood sample is obtained through venipuncture, which involves inserting a needle into a vein, typically in the arm. This step is crucial as it provides the serum needed for testing. The blood is collected in a sterile container to prevent contamination.
  • Step 3: Serum Separation - After collection, the blood sample is processed to separate the serum from the cellular components. This is typically done by centrifugation, which spins the sample at high speeds to separate the liquid serum from the solid elements.
  • Step 4: Gas Chromatography Analysis - The separated serum is then analyzed using gas chromatography, a sophisticated technique that allows for the precise measurement of ketone bodies. This method involves vaporizing the serum and passing it through a column where different components are separated and quantified based on their chemical properties.
  • Step 5: Result Interpretation - Once the analysis is complete, the results are interpreted by a qualified healthcare professional. The quantitative levels of ketone bodies are reported, which can then be used to guide clinical decisions regarding patient management.

3. Post-Procedure

After the quantitative test for ketone bodies is completed, there are several considerations for post-procedure care. Patients may be advised to resume normal activities unless otherwise directed by their healthcare provider. It is important for healthcare professionals to communicate the results of the test to the patient, discussing any necessary follow-up actions based on the ketone levels measured. If elevated levels are detected, further evaluation and management may be required to address underlying conditions such as diabetic ketoacidosis or other metabolic disorders. Additionally, patients should be monitored for any symptoms that may arise, particularly if they have a history of conditions associated with ketone production.

Short Descr KETONE BODYS QUAN
Medium Descr KETONE BODYS QUANTITATIVE
Long Descr Ketone body(s) (eg, acetone, acetoacetic acid, beta-hydroxybutyrate); quantitative
Status Code Statutory Exclusion (from MPFS, may be paid under other methodologies)
Global Days XXX - Global Concept Does Not Apply
PC/TC Indicator (26, TC) 9 - Not Applicable
Multiple Procedures (51) 9 - Concept does not apply.
Bilateral Surgery (50) 9 - Concept does not apply.
Physician Supervisions 09 - Concept does not apply.
Assistant Surgeon (80, 82) 9 - Concept does not apply.
Co-Surgeons (62) 9 - Concept does not apply.
Team Surgery (66) 9 - Concept does not apply.
Diagnostic Imaging Family 99 - Concept Does Not Apply
CLIA Waived (QW) Yes
APC Status Indicator Conditionally packaged laboratory tests
Type of Service (TOS) 5 - Diagnostic Laboratory
Berenson-Eggers TOS (BETOS) T1H - Lab tests - other (non-Medicare fee schedule)
MUE 1
CCS Clinical Classification 233 - Laboratory - Chemistry and Hematology
90 Reference (outside) laboratory: when laboratory procedures are performed by a party other than the treating or reporting physician or other qualified health care professional, the procedure may be identified by adding modifier 90 to the usual procedure number.
26 Professional component: certain procedures are a combination of a physician or other qualified health care professional component and a technical component. when the physician or other qualified health care professional component is reported separately, the service may be identified by adding modifier 26 to the usual procedure number.
QW Clia waived test
GW Service not related to the hospice patient's terminal condition
GV Attending physician not employed or paid under arrangement by the patient's hospice provider
Q4 Service for ordering/referring physician qualifies as a service exemption
59 Distinct procedural service: under certain circumstances, it may be necessary to indicate that a procedure or service was distinct or independent from other non-e/m services performed on the same day. modifier 59 is used to identify procedures/services, other than e/m services, that are not normally reported together, but are appropriate under the circumstances. documentation must support a different session, different procedure or surgery, different site or organ system, separate incision/excision, separate lesion, or separate injury (or area of injury in extensive injuries) not ordinarily encountered or performed on the same day by the same individual. however, when another already established modifier is appropriate it should be used rather than modifier 59. only if no more descriptive modifier is available, and the use of modifier 59 best explains the circumstances, should modifier 59 be used. note: modifier 59 should not be appended to an e/m service. to report a separate and distinct e/m service with a non-e/m service performed on the same date, see modifier 25.
76 Repeat procedure or service by same physician or other qualified health care professional: it may be necessary to indicate that a procedure or service was repeated by the same physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 76 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
77 Repeat procedure by another physician or other qualified health care professional: it may be necessary to indicate that a basic procedure or service was repeated by another physician or other qualified health care professional subsequent to the original procedure or service. this circumstance may be reported by adding modifier 77 to the repeated procedure or service. note: this modifier should not be appended to an e/m service.
91 Repeat clinical diagnostic laboratory test: in the course of treatment of the patient, it may be necessary to repeat the same laboratory test on the same day to obtain subsequent (multiple) test results. under these circumstances, the laboratory test performed can be identified by its usual procedure number and the addition of modifier 91. note: this modifier may not be used when tests are rerun to confirm initial results; due to testing problems with specimens or equipment; or for any other reason when a normal, one-time, reportable result is all that is required. this modifier may not be used when other code(s) describe a series of test results (eg, glucose tolerance tests, evocative/suppression testing). this modifier may only be used for laboratory test(s) performed more than once on the same day on the same patient.
RT Right side (used to identify procedures performed on the right side of the body)
Date
Action
Notes
2025-01-01 Changed Short and Medium Descriptions changed.
2013-01-01 Changed Description Changed
Pre-1990 Added Code added.
Code
Description
Code
Description
CasePilot

Get instant expert-level medical coding assistance.

Ask about:
CPT Codes Guidelines Modifiers Crosswalks NCCI Edits Compliance Medicare Coverage
Example: "What is CPT code 99213?" or "Guidelines for E/M services"